CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions

  • Mohammadreza Akhavanpoor, Christian A Gleissner, Stephanie Gorbatsch, Andreas Doesch, Hamidreza Akhavanpoor, Susanne Wangler, Frederik Jahn, Felix Lasitschka, Hugo Katus, Christian Erbel
  • Drug Design Development and Therapy, November 2014, Taylor & Francis
  • DOI: 10.2147/dddt.s72394

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/dddt.s72394

The following have contributed to this page: Dr Mohammadreza Akhavanpoor, Christian Gleißner, and Hugo Katus